Posts

Showing posts with the label Invasive Candidiasis market outlook

Invasive Candidiasis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Invasive candidiasis is an infection caused by a type of fungus called Candida is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candida species are frequent colonizers of the human alimentary tract and skin that have emerged as important nosocomial pathogens, in tandem with advances in modern medical therapeutics. Risk factors for invasive candidiasis include exposure to broad-spectrum antibiotics and cancer chemotherapy, advanced care of premature neonates, major abdominal surgery, organ transplantation, prolonged stay in an intensive care setting, and implanted medical devices such as vascular catheters and prosthetic heart valves, and parenteral feeding. Recent treatment directives have been shaped by the widespread introduction of echinocandins, highly potent and safe antifungals, into clinical use, essential changes in drug susceptibility patterns, and the emergence of known and novel drug-resistant drugs Candida specie...

Invasive Candidiasis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Invasive candidiasis is an infection caused by a type of fungus called Candida is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candida species are frequent colonizers of the human alimentary tract and skin that have emerged as important nosocomial pathogens, in tandem with advances in modern medical therapeutics. Risk factors for invasive candidiasis include exposure to broad-spectrum antibiotics and cancer chemotherapy, advanced care of premature neonates, major abdominal surgery, organ transplantation, prolonged stay in an intensive care setting, and implanted medical devices such as vascular catheters and prosthetic heart valves, and parenteral feeding. Recent treatment directives have been shaped by the widespread introduction of echinocandins, highly potent and safe antifungals, into clinical use, essential changes in drug susceptibility patterns, and the emergence of known and novel drug-resistant drugs Candida specie...